Diabetes devices join New Zealand subsidy net:
This article was originally published in Clinica
New Zealand's drug reimbursement agency, Pharmac, began subsidising several new diabetes products on September 1, reports GP Weekly. The products include a pen needle and a new cartridge-loaded blood glucose test strip. The number of syringes now being subsidised has risen from 26 to 50 over a three-month period.
You may also be interested in...
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.
Accelerated approval in epithelial sarcoma may de-risk the firm’s goals for approval of Tazverik in follicular lymphoma and other larger indications.